206 related articles for article (PubMed ID: 14741836)
1. Use of botulinum toxin in facial paralysis.
de Maio M
J Cosmet Laser Ther; 2003 Dec; 5(3-4):216-7. PubMed ID: 14741836
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injection in long-standing facial paralysis patients: improvement of facial symmetry observed up to 6 months.
Salles AG; Toledo PN; Ferreira MC
Aesthetic Plast Surg; 2009 Jul; 33(4):582-90. PubMed ID: 19330369
[TBL] [Abstract][Full Text] [Related]
3. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
Krohel GB; Cipollo CL; Gaddipati K
Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
[TBL] [Abstract][Full Text] [Related]
4. The use of botulinum toxin A in perioral rejuvenation.
Kaplan SE; Sherris DA; Gassner HG; Friedman O
Facial Plast Surg Clin North Am; 2007 Nov; 15(4):415-21, v-vi. PubMed ID: 18005882
[TBL] [Abstract][Full Text] [Related]
5. [Maxillofacial cosmetic indications for type A botulinic toxin].
Franchi G
Rev Stomatol Chir Maxillofac; 2003 Sep; 104(4):223-5. PubMed ID: 14631233
[No Abstract] [Full Text] [Related]
6. Neuromuscular retraining for facial paralysis.
Diels HJ; Combs D
Otolaryngol Clin North Am; 1997 Oct; 30(5):727-43. PubMed ID: 9295250
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin in facial palsy: an effective treatment for contralateral hyperkinesis.
de Maio M; Bento RF
Plast Reconstr Surg; 2007 Sep; 120(4):917-927. PubMed ID: 17805119
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A: fine-tuning treatment of facial nerve injury.
Finn JC
J Drugs Dermatol; 2004; 3(2):133-7. PubMed ID: 15098967
[TBL] [Abstract][Full Text] [Related]
9. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
Geddoa E; Balakumar AK; Paes TR
Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
[TBL] [Abstract][Full Text] [Related]
10. [Manktelow's test for the use of botulic toxin].
Guerreschi P; Labbé D; Carluer L; Drillet C; Bénateau H
Ann Chir Plast Esthet; 2008 Feb; 53(1):59-62. PubMed ID: 17600609
[TBL] [Abstract][Full Text] [Related]
11. Contralateral botulinum injections in patients with residual facial asymmetry and contralateral hyperkinesis after primary facial palsy surgery.
Bartoli D; Battisti A; Cassoni A; Terenzi V; Della Monaca M; Pagnoni M; Valentini V; Priore P
Ann Ital Chir; 2015; 86(3):201-6. PubMed ID: 26229045
[TBL] [Abstract][Full Text] [Related]
12. The role of botulinum toxin a in the establishment of symmetry in pediatric paralysis of the lower lip.
Haykal S; Arad E; Bagher S; Lai C; Hohman M; Hadlock T; Zuker RM; Borschel GH
JAMA Facial Plast Surg; 2015; 17(3):174-8. PubMed ID: 25742503
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of botulinum toxins in oral and maxillofacial surgery.
Majid OW
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):197-207. PubMed ID: 19959337
[TBL] [Abstract][Full Text] [Related]
14. Facial rejuvenation using botulinum toxin A: review and updates.
Vartanian AJ; Dayan SH
Facial Plast Surg; 2004 Feb; 20(1):11-9. PubMed ID: 15034809
[TBL] [Abstract][Full Text] [Related]
15. The role of botulinum toxin in the management of head and neck cancer patients.
Laskawi R; Ellies M
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):112-6. PubMed ID: 17413413
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: a case report.
Riemann R; Pfennigsdorf S; Riemann E; Naumann M
Ophthalmology; 1999 Dec; 106(12):2322-4. PubMed ID: 10599665
[TBL] [Abstract][Full Text] [Related]
17. Incidental finding of dysgeusia relieved by injections of botulinum toxin A.
Heman-Ackah S; Pensak MA
Laryngoscope; 2005 May; 115(5):844-5. PubMed ID: 15867651
[TBL] [Abstract][Full Text] [Related]
18. UNILATERAL FRONTALIS MUSCLE PARALYSIS: MANAGEMENT WITH BOTULINUM TOXIN A (CASE REPORTS).
Goldman A; Wollina U
Georgian Med News; 2018 Feb; (Issue):73-77. PubMed ID: 29578428
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin in aesthetic applications: 'how often misused words generate misleading thoughts'. (Response to: De Boulle K. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther. 2008;10:87-92).
Pickett A; Rzany B
J Cosmet Laser Ther; 2009 Sep; 11(3):178-9; author reply 180-1. PubMed ID: 19337943
[No Abstract] [Full Text] [Related]
20. The treatment of masseter hypertrophy with botulinum toxin type A.
Al-Ahmad HT; Al-Qudah MA
Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
